Xilio Therapeutics Inc
(NAS:XLO)
$
0.9023
0.0109 (1.22%)
Market Cap: 39.66 Mil
Enterprise Value: -27.09 Mil
PE Ratio: 0
PB Ratio: 1.17
GF Score: 16/100 Xilio Therapeutics Inc (XLO) Transcripts
- Xilio Therapeutics Inc Pipeline Progress and SITC Update TranscriptNov 06, 2023
- Xilio Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Xilio Therapeutics Inc Spotlight Program TranscriptAug 17, 2023
- Xilio Therapeutics Inc at Citi Virtual Oncology Leadership Summit TranscriptFeb 23, 2023
- Xilio Therapeutics, Inc. - Special Call TranscriptDec 01, 2022
- Xilio Therapeutics Inc at Cowen IO Next Summit (Virtual) TranscriptNov 11, 2022
- Xilio Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Xilio Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 13, 2022
- 1